Copulabis is a Belgian biotechnology company and spin‑out from VIB/UGent that is developing a novel class of small‑molecule therapeutic agents designed to selectively target and modulate specific immune cell interactions implicated in cancer, autoimmunity and inflammatory diseases. Lab Technician /